TDACW NASDAQ
Translational Development Acquisition Corp.
1W: -8.5%
1M: -15.2%
3M: -2.1%
YTD: +351.6%
$1.40
-0.05 (-3.45%)
Weekly Expected Move ±12.3%
$1
$1
$1
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
-100.0% ▼
Operating Income
-$945K
-381.0% ▼
Net Income
$6M
+9059.7% ▲
EPS (Diluted)
$0.37
+2384.0% ▲
EBITDA
-$945K
-1230.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2025 |
|---|---|
| Revenue | $0 |
| YoY Growth | -100.0% |
| Cost of Revenue | $0 |
| Gross Profit | $0 |
| Gross Margin | — |
| R&D Expenses | $0 |
| SG&A Expenses | $945K |
| Operating Expenses | $945K |
| Operating Income | -$945K |
| Operating Margin | — |
| Interest Expense | $0 |
| Income Before Tax | $6M |
| Tax Expense | $0 |
| Net Income | $6M |
| Net Margin | — |
| EPS (Diluted) | $0.37 |
| EBITDA | -$945K |
| Shares Outstanding | 17M |